Blood Research

Characteristics at the time of HCC diagnosis and treatment course.

Case Age at
HCC diagnosis, years
Sex Etiology N of
TACE cycle (s)
Cumulative dose ofdoxorubicin (mg) Use of sorafenib Radiation
therapy
1 46 Male HBV 4 80 No No
2 45 Male HBV 2 60 No No
3 64 Male Alcohol 5 180 No Yes
4 63 Male HBV 2 100 No No
5 64 Male HBV 10 500 Yes No
6 58 Male Alcohol 14 700 Yes No
7 54 Male Alcohol 4 200 No No
8 67 Male Cryptogenic 4 200 No No

Abbreviations: HBV, hepatitis B virus; HCC, hepatocellular carcinoma; TACE, transcatheter arterial chemoembolization.

Blood Res 2021;56:349~353 https://doi.org/10.5045/br.2021.2021197
© Blood Research
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd